Clinical Trial Update: Vorinostat Plus Lenalidomide and Dexamethasone or Lenalidomide Plus Dexamethasone in Multiple Myeloma Patients Who Experience Biochemical Relapse During Lenalidomide Maintenance Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating vorinostat plus lenalidomide and dexamethasone versus lenalidomide and dexamethasone in multiple myeloma patients who experience bioche…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)
• Vorinostat (vorinostat)

Snippet

Sponsor: Tiziana Marangon | Conditions: Multiple Myeloma | Phase 2 | Status: WITHDRAWN